에 대한 최신 뉴스 AIFU (NASDAQ:AIFU) 주식

Fanhua

AIFU Inc is an independent financial services provider in China. It offer end-to-end business solutions spanning compliance, technology, products, services, operations, capital flow, and professional training. It connects customers with insurance protection, retirement planning, health management, asset management, and family governance services.

AIFU Inc

Aiful Corp

IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) held its Think 2025 event in <a href="https://www.benzinga.com/25/05/45259042/ibm-thinks-big-ai-delivers-bigger-why-bulls-are-charging-toward-300">Boston on Tuesday. </a> 
The key takeaway from the event is the company's portfolio of software products and services being "integral to large enterprise customers as they leverage AI across their organizations," according to Goldman Sachs.
The IBM Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5805f8a2846faa000106ab15/james-schneider">Analyst James Schneider</a> maintained a Buy rating and price target of $270.
The IBM Thesis: The company launched LinuxONE 5, which enables 450 billion secure AI inference operations per day, Schneider said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The company also introduced an upgraded watsonx.data, which taps unstructured data to increase accuracy of AI agents, he added.
"CEO Arvind Krishna noted that AI is shifting from experimentation to delivering measurable business value, with an emphasis on productivity and cost efficiency," the analyst wrote.
IBM projected that AI agents could power 30% of the one billion new applications by 2028, he further stated.
By applying its AI solutions internally, the company can "support ongoing margin expansion and FCF growth &#8211; even as it executes on M&amp;A," Schneider said.
IBM Price Action: Shares of IBM were up 1.1% to $252.02 at the time of publication on Wednesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45218573/ibms-ai-watsonx-integrates-with-oracle-cloud-to-boost-enterprise-productivity">IBM AI Watsonx Integrates With Oracle Cloud To Boost Enterprise Productivity</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Reiteration

Analyst Ratings

Movers

Trading Ideas

IBM's AI Push Takes Center Stage At Think 2025, Goldman Sees Path To Margin Growth

WIIM

XChange TEC.INC shares are trading lower after the company announced plans to change its ADS ratio from 1-to-120 to 1-to-2400.

Hedge Funds

General

Doubleline Capital's Gundlach Says We're In A Risk-off Market On Intermediate Term Basis

GLBZ

Glen Burnie shares are trading lower after the company reported a year-over-year decrease in Q1 sales results.

Chardan Research initiated coverage on Praxis Precision Medicines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) on Wednesday, citing the potential of its <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">epilepsy franchise</a>.
Analyst Rudy Li writes, &#8220;Epilepsy remains one of our favorite markets in the CNS space, and we view Praxis as a diversified play in epilepsy, with a portfolio of products leveraging validated drug targets.&#8221;
Praxis had $472.0 million in cash, cash equivalents, and marketable securities as of March 31, which is expected to fund operations into 2028.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40691948/praxis-precision-medicines-touts-encouraging-data-for-mid-stage-epilepsy-drug" rel="noreferrer noopener">Praxis Precision Medicines Touts Encouraging Data For Mid-Stage Epilepsy Drug</a>
In March, Praxis released interim data from Study 1 of the Essential3 program of ulixacaltamide&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44087912/analyst-cut-price-targets-for-praxis-precision-after-trial-setback-for-essential-tremor-candidate" rel="noreferrer noopener">in essential tremor (ET)</a>.
The Independent Data Monitoring Committee recommended stopping the study for futility. The results are unlikely to meet the primary efficacy endpoint.
<ul>
<li>&#8220;While we believe that the Phase 3 studies are unlikely to work (and we have not modeled for), we believe it is also possible that the FDA could provide regulatory flexibility given the unmet need for ET, which could provide additional upside to the story,&#8221; analyst Li writes.</li>
<li>In its first-quarter earnings release, the company said it decided to complete the studies and will share topline results in the third quarter of 2025. After reviewing the results of both studies, Praxis will decide if there is sufficient evidence to <a href="https://www.benzinga.com/pressreleases/25/05/g45164110/praxis-precision-medicines-provides-corporate-update-and-reports-first-quarter-2025-financial-resu" target="_blank" rel="noreferrer noopener">support an NDA filing</a>.</li>
</ul>
The analyst initiated with a Buy rating and a<a target="_blank" href="https://www.benzinga.com/quote/PRAX/analyst-ratings" rel="noreferrer noopener"> price forecast of $80</a>.
Chardan is optimistic <a target="_blank" href="https://www.benzinga.com/general/biotech/24/03/37941441/why-praxis-precision-medicines-stock-is-trading-higher-tuesday" rel="noreferrer noopener">about vormatrigine&#8217;s (formerly PRAX-628) potential</a> in treating major types of epilepsy, especially focal onset seizures and generalized epilepsy, with possible peak sales over $1 billion.
<ul>
<li>As a next-generation sodium channel modulator, vormatrigine stands out from older drugs and current standard treatments because of its strong potency and targeted action, which could lead to better effectiveness and fewer side effects.</li>
<li>Early trials showed it has a wide safety margin, and a separate study showed high response rates in patients with light-triggered seizures.</li>
</ul>
Talking about Praxis&#8217;s elsunersen, an antisense product, Chardan writes that the product could become the first disease-modifying therapy for the treatment of SCN2A Gain-of-Function (GoF) DEE, which is a rare indication (~2K patients)
Price Action: PRAX stock is up 7.31% at $37.74 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/05/45257204/chinese-biotech-beigene-stock-falls-despite-strong-brukinsa-sales-and-earnings-beat" target="_blank" rel="noreferrer noopener">Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat</a></li>
</ul>
Photo: Shutterstock

Biotech

News

Health Care

Initiation

PRAX

Praxis Precision Medicines 'A Diversified Player In Epilepsy Market,' Analyst Sees Over 100% Stock Upside

DRCT

Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, Benchmark lowered its price target on the stock from $8 to $6.

ASST

Asset Entities Shares Halted On Circuit Breaker To The Upside, Stock Now Up 345.9%

Applovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) shares are facing selling pressure again after short seller Muddy Waters Research released a bearish report on the company, which follows an initial <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44524167/applovin-shares-fall-20-following-muddy-waters-report-on-alleged-platform-violations-whats-going-on">short report from March</a>. 
What To Know: AppLovin shares sold off in March after Muddy Waters announced a short position, calling AppLovin &#8220;another scammy adtech company&#8221; that relies on retargeting for e-commerce conversions.
AppLovin executives responded to the short report in a <a href="https://www.applovin.com/blog/note-from-our-ceo-2/">blog post</a> that Muddy Waters says includes &#8220;demonstrably false&#8221; statements. The company also hired a law firm to perform &#8220;an independent review and investigation into recent short report activity targeting the Company.&#8221;
Muddy Waters on Wednesday alleged that AppLovin continues to use persistent identifiers that violate user privacy and partner&#8217;s terms of service, which AppLovin executives denied in a subsequent <a href="https://www.applovin.com/blog/how-we-drive-value-and-handle-data/">blog post</a>, the short seller said. 
Benzinga has reached out to AppLovin for comment on the report. 
&#8220;On March 31, Foroughi denied that APP creates or uses persistent identity graphs (PIGs) for users who decline IDFA cross &#8211; application tracking. On May 1, APP re-upped Foroughi's lie by recycling his March 31 post in a newsletter to stakeholders,&#8221; Muddy Waters said. 
&#8220;This presentation and the accompanying video show records of web and application traffic that prove these claims to be utterly false. We show that persistent identifiers are created, disguised, and applied to track users across domains and applications.&#8221;
The full short report can be found <a href="https://muddywatersresearch.com/wp-content/uploads/2025/05/MW_APP_20250507.pdf">here</a>. Benzinga&#8217;s previous coverage is also available via <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44524167/applovin-shares-fall-20-following-muddy-waters-report-on-alleged-platform-violations-whats-going-on">this link</a>. 
AppLovin is due to report first-quarter financial results after the market close on Wednesday. Analysts expect the company to report earnings of $1.45 per share and revenue of $1.38 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Investors will be watching for a potential response from the company in the earnings call, scheduled for 5 p.m. ET.
APP Price Action: AppLovin shares were down 2.4% at $297.30 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
AppLovin shares are down about 8% year-to-date, but the stock is still up more than 300% over a one-year period.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45126778/short-seller-jim-chanos-slams-trumps-reindustrialization-hopes-says-3-per-hour-apple-supplier-foxconn-workers-were-too-expensive-questions-if-those-jobs">Short Seller Jim Chanos Slams Trump&#8217;s Reindustrialization Hopes: Says $3-Per-Hour Apple Supplier Foxconn Workers Were &#8216;Too Expensive&#8217; — Questions If &#8216;Those Jobs Are Coming Back&#8217;</a></li>
</ul>
Photo: Shutterstock.

Short Sellers

Muddy Waters Doubles Down On AppLovin In New Short Report Ahead Of Q1 Earnings

Shares of DoorDash Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) tanked in early trading on Wednesday after the company announced downbeat first-quarter sales on Tuesday.
Here are some key analyst takeaways.
Wedbush On DoorDash
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58459503ee7bf6000154d075/scott-devitt">Analyst Scott Devitt</a> maintained a Neutral rating while raising the price target from $190 to $200.
DoorDash's revenue grew 20.7% year-on-year to $3.0 billion but came in below Street expectations of 22.8% growth, Devitt said in a note. He added, however, that the company's Gross Order Value (GOV) grew by $23.1 billion, ahead of consensus estimates of $22.9 billion.
Management guided to GOV growth in the range of 18.2%-20.2% for the second quarter, beating consensus by around 90 basis points at the midpoint "as the company continues to execute on its growth initiatives across international markets and new verticals," the analyst stated. "Despite ongoing macro uncertainty in the US, we are encouraged by the growth trajectory for the full year implied by the strength of the 2Q GOV guide," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Needham On DoorDash
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587635595064ed000140010c/scott-berg">Analyst Bernie McTernan</a> reaffirmed a Buy rating, while lifting the price target from $225 to $230.
McTernan said DoorDash announced the acquisitions of UK-based Deliveroo and hospitality software operator SevenRooms. While Deliveroo helps the company expand its total addressable market, SevenRooms complements the capabilities of its commerce platform.
DoorDash generated 19.9% year-on-year GOV growth in the first quarter and guided to 19.2% growth in the second quarter, the analyst stated. The company's better bookings performance is being driven by investments in affordability, which could pressure margins in the near-term margin but "should pay off over the long-term given the higher order frequency and retention of DashPass subscribers," he wrote.
Cantor Fitzgerald On DoorDash
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/596f57cb35f48b00011db3ec/deepak-mathivanan">Analyst Deepak Mathivanan</a> reiterated an Overweight rating and price target of $210.
DoorDash first-quarter performance and second-quarter guidance reflect that "fundamentals remain solid," Mathivanan said. The company's guidance GOV growth guidance indicates "relatively stable growth rates," while its EBITDA outlook "points to healthy incremental margins and steady margin expansion," he added.
The analyst wrote that DoorDash will likely exhibit "better resiliency during macro volatility.&#8221; The recently announced acquisitions of Deliveroo and SevenRooms should enable the company to expand into new geographies and "enhance the platforms&#8217; restaurant services," he stated.
DASH Price Action: At the time of publication on Wednesday, shares of DoorDash had declined by 6.14% to $178.44.
Read More: <a href="https://www.benzinga.com/news/25/04/45045012/sabre-divests-hospitality-arm-tpg-plans-debt-reductioncore-platform-focus"> DoorDash To Boost Global Presence With $3.9 Billion Acquisition Of UK&#8217;s Deliveroo</a>
Photo: Shutterstock

Earnings Beats

Price Target

DASH

DoorDash Misses On Q1 Sales But 2025 Order Outlook Sparks Price Target Hikes

<a href="https://www.youtube.com/watch?v=M1STr27Vbts">https://www.youtube.com/watch?v=M1STr27Vbts</a>
&nbsp;

Macro Economic Events

Economics

Federal Reserve

Fed Chair Powell Says We Can Afford To Be Patient, No Real Cost To Our Waiting; Not Dismissing Soft Data, But The Link Between Consumer Sentiment And Demand In Recent Years Was Weak, This Is An Outsized Changed In Sentiment Though; We Can Be More, Or Less, Supportive Of Demand; That's An Inefficient Way To Address Supply Chain Issues

Flotek Industries shares are trading higher after the company reported better-than-expected Q1 financial results.

CURI

CuriosityStream shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance above estimates.

Fed Chair Powell Says Now In A New Phase Where Administration Is Beginning Trade Talks, Has Potential To Change Picture Materially Or Not; Trade Issues Are 'For The Administration To Do'; Big Spike In Imports To Beat Tariffs Should Reverse In Q2, Likely Net Exports To Have Large Positive Contribution To GDP; Will Be Harder To Make A Clean Assessment Of U.S. Demand, Final Sales To Private Domestic Buyers Was Likely Flattered A Bit By Front Running

Offerings

Spire Files For Mixed Shelf Offering; Size Not Disclosed

Eos Energy Enterpises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) shares are trading higher Wednesday after the company reported better-than-expected <a href="https://www.benzinga.com//node/45235078">first-quarter financial results.</a>
What To Know: Eos reported a loss of 17 cents, beating the consensus estimate of a 21 cent-loss. In addition, the company reported sales of $10.46 million, beating the consensus estimate of $10.40 million and representing a 58% year-over-year increase.
The company ended the quarter with $111.7 million in cash. It also reported a commercial opportunity pipeline of $15.6 billion.
&#8220;The Eos team delivered solid operating results. We are starting to see the product cost-out benefits combined with higher manufacturing output,&#8221; said Joe Mastrangelo, Eos CEO.
&#8220;Year-to-date, the team has already surpassed total 2024 shipments, and during&nbsp;Q1&nbsp;the operations team set production records across all key processes showing the ability to scale operations. We continue to position the Company for long-term profitable growth and believe that American-made long duration energy storage will play a critical role in helping the country achieve energy independence.&#8221;
Outlook: The company sees fiscal-year sales from $150 million to $190 million, versus the consensus estimate of $167.08 million.
See Also: <a href="https://www.benzinga.com/news/global/25/05/45261215/whats-going-on-with-zeekr-stock-today">What&#8217;s Going On With Zeekr Stock Today?</a>
EOSE Price Action: At the time of writing, Eos stock is trading 32% higher at $6.64, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: via Shutterstock

EOSE

Eos Energy Stock Is Moving Higher: What's Going On?

Fed Chair Powell Says Fortunately Since Then Unemployment Rate Has Been Moving Sideways; So Concern About Further Cooling Has Gotten A Lot Less; Can't Say How Much Of A Rise In Unemployment Rate Is Tolerable; Need To Look At Both Unemployment And Inflation; If Did See Significant Labor Market Deterioration, Of Course We Would Look To Be Able To Support That; Would Hope That At Same Time Inflation Was Not Getting Very Bad; Will Have To Wait And See

Comstock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LODE#AMEX">LODE</a>) is preparing to release its quarterly earnings on Thursday, 2025-05-08. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Comstock to report an earnings per share (EPS) of $-0.20.
The announcement from Comstock is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.14 in the last quarter, leading to a 1.89% drop in the share price on the following day.

<img src="https://www.benzinga.com/files/images/story/2025/1746644757_0.png" alt="eps graph" />
<h3>Tracking Comstock's Stock Performance</h3>
Shares of Comstock were trading at $2.54 as of May 06. Over the last 52-week period, shares are down 10.82%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/LODE/earnings">To track all earnings releases for Comstock visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

LODE

Insights Ahead: Comstock's Quarterly Earnings

Investors with a lot of money to spend have taken a bullish stance on Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TTWO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Take-Two Interactive.
This isn't normal.
The overall sentiment of these big-money traders is split between 53% bullish and 46%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $358,754, and 4 are calls, for a total amount of $303,544.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $195.0 to $290.0 for Take-Two Interactive over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Take-Two Interactive's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Take-Two Interactive's substantial trades, within a strike price spectrum from $195.0 to $290.0 over the preceding 30 days.
<h3>Take-Two Interactive 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746644697_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TTWO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.2</td>
<td>$8.9</td>
<td>$8.96</td>
<td>$240.00</td>
<td>$178.3K</td>
<td>1.5K</td>
<td align="right">0</td>
</tr>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$11.3</td>
<td>$11.1</td>
<td>$11.3</td>
<td>$230.00</td>
<td>$88.1K</td>
<td>451</td>
<td align="right">104</td>
</tr>
<tr>
<td>TTWO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$230.00</td>
<td>$72.1K</td>
<td>444</td>
<td align="right">111</td>
</tr>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/23/25</td>
<td>$1.45</td>
<td>$1.3</td>
<td>$1.45</td>
<td>$200.00</td>
<td>$48.1K</td>
<td>47</td>
<td align="right">332</td>
</tr>
<tr>
<td>TTWO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$0.85</td>
<td>$0.8</td>
<td>$0.8</td>
<td>$197.50</td>
<td>$47.2K</td>
<td>37</td>
<td align="right">589</td>
</tr>
</tbody>
</table>

<h3>About Take-Two Interactive</h3>
Take-Two is one of the largest global developers and publishers of video games, with labels including Rockstar, 2K, and Zynga. Grand Theft Auto is the firm's biggest franchise, accounting for about 30% of total sales for the past decade. NBA 2K is the industry's dominant basketball video game, with Take-Two releasing a new version annually. Other notable franchises include Red Dead Redemption, Borderlands, and Civilization. Typically, more than three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales. Since acquiring Zynga in 2022, mobile makes up about half of total sales.
<h3>Take-Two Interactive's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,409,616, the TTWO's price is up by 0.28%, now at $232.5. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 8 days.</li>
</ul>
<h3>Expert Opinions on Take-Two Interactive</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $223.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from BMO Capital downgraded its rating to Outperform, setting a price target of $236. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Take-Two Interactive, maintaining a target price of $210. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Take-Two Interactive, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

TTWO

Unpacking the Latest Options Trading Trends in Take-Two Interactive

Fed Chair Powell Says Data Could Break In A Way That It Favors One Goal Or The Other; Right Now There Is No Need To Make A Choice, No Basis For Doing So; Congress Doesn't Need My Advice On Fiscal Policy; U.S. Debt Is On Unsustainable Path; Last Year, When Said We Would Not Welcome Further Labor Market Cooling, The Unemployment Rate Had Been Rising , A Very Obvious Concern About Downside Risks To Labor Market

Benzinga's options scanner has just identified more than 14 option transactions on Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), with a cumulative value of $509,899. Concurrently, our algorithms picked up 8 puts, worth a total of 380,615.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $70.0 to $130.0 for Target over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Target stands at 1112.0, with a total volume reaching 1,148.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Target, situated within the strike price corridor from $70.0 to $130.0, throughout the last 30 days.
<h3>Target Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746644692_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$23.4</td>
<td>$22.85</td>
<td>$23.01</td>
<td>$110.00</td>
<td>$161.0K</td>
<td>304</td>
<td align="right">70</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/13/25</td>
<td>$5.9</td>
<td>$5.8</td>
<td>$5.8</td>
<td>$96.00</td>
<td>$52.2K</td>
<td>90</td>
<td align="right">91</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$2.97</td>
<td>$2.94</td>
<td>$2.97</td>
<td>$120.00</td>
<td>$40.6K</td>
<td>4.1K</td>
<td align="right">247</td>
</tr>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$8.0</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$95.00</td>
<td>$39.7K</td>
<td>1.7K</td>
<td align="right">54</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$15.75</td>
<td>$15.45</td>
<td>$15.65</td>
<td>$90.00</td>
<td>$39.1K</td>
<td>1.0K</td>
<td align="right">25</td>
</tr>
</tbody>
</table>

<h3>About Target</h3>
Target serves as the nation's seventh-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a leading US retailer.Today, Target operates over 1,900 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast footprint is typically concentrated in urban and suburban markets as the firm seeks to attract a more affluent consumer base.
Following our analysis of the options activities associated with Target, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Target</h3>
<ul>
<li>Currently trading with a volume of 2,913,454, the TGT's price is up by 2.0%, now at $95.53. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 14 days.</li>
</ul>
<h3>What The Experts Say On Target</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $92.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Mizuho downgraded its rating to Neutral, setting a price target of $92. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Target with a target price of $95. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Hold rating for Target, targeting a price of $82. 
&#x2A; An analyst from Goldman Sachs has revised its rating downward to Neutral, adjusting the price target to $101. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Target options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Target Unusual Options Activity

Press Releases

Fanhua Announces Change of Name to AIX Inc. and the Results of its Extraordinary General Meeting

Management

AIX Announces Changes to the Board of Directors and Management Team

Financing

AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI

Insurance

BGM Group Ltd. Pioneers Innovation in AI and Intel Technology, Fostering Holistic Integration of Healthcare and Insurtech

AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead?

/C O R R E C T I O N -- BGM Group Ltd/

AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare

AIX Announces Receipt of Minimum Bid Price Notice from Nasdaq

AIFU Files Annual Report on Form 20-F on April 25, 2025

AIFU

FANH

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Cos

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Waterdrop

Willis Towers Watson Public Limited Company - Ordinary Shares

Willis Towers Watson

XChange TEC.INC - American Depositary Shares

XChange Tec

Zhibao Technology Inc. - Class A Ordinary Shares

Comments

AIFU

뉴스

에 대한 최신 뉴스 AIFU (NASDAQ:AIFU) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌